
Dermatotoxicity of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: Current Advances in Mechanistic ...
Introduction Lung cancer remains a leading cause of global cancer-related incidence and mortality.1 Over the past decade, immune checkpoint inhibitors (ICIs) have substantially reshaped the treatment paradigm for advanced and metastatic non-small cell lung …